Board of Directors


David Ljungström is the Managing Vice President of ALTEN Northern Perimeter which includes the Nordic countries and Switzerland, responsible for +2500 consultants helping ALTEN customers with services within R&D Engineering, Pharma and IT. David is responsible for Operations, M&A activities and he is a member of the ALTEN International One Steering Committee. He has a long experience of consulting and software business. Being an angel investor and a former management consultant, he has several Board assignments, including at Handelsbanken and Wehunt AB. David rejoined ALTEN in 2015, and was also part of the company 2003-2011. David is the chairman of Larix' Board of Directors.


Jean-Christophe Franoux is Managing Director of AIXIAL, the CRO of ALTEN GROUP.
Jean-Christophe FRANOUX has previously served as Director of Business Unit and Director of Business Development, where he was responsible for overseeing the company’s business in the CRO industry during 12 years. Prior to this he worked as consultant in the pharmaceutical industry. Jean-Christophe received his master of business engineering from « EBI » and his master of science in Biology and Genetic from the University « Pierre et Marie Curie » of Paris . Jean-Christophe joined ALTEN and AIXIAL in 2016.


Klaus Juel Olsen has an MSC and PhD in statistics from the Technical University of Denmark (1988). After 5 years as a biostatistician within agricultural research, Klaus joined the pharmaceutical industry in 1994. Until 1999 Klaus worked in different positions in Novo Nordisk, mainly as a project statistician in clinical development but also within the Enzyme Business division. Following this, Klaus was for 2 years the head of Biometrics in Nycomed covering statistics, data management and medical writing. Ultimo 2001 Klaus founded Larix and has since then been the CEO and head of statistics. From 2005 until 2011 Klaus was President of the Danish Society of Biopharmaceutical Statistics. From the merger with ALTEN, effective 28 June 2019, Klaus has continued in the role as Managing Director for Larix.